Results

Total Results: 3,707 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

2581. Infectious Disease Including HIV/AIDS #09 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
      January 01, 2012 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … As the first class of new therapies for HCV treatment in 20 years and the first class of direct-acting … As the first class of new therapies for HCV-infection treatment in 20 years and the first class of … treatments would significantly shift treatment or management models. … therapy was five before treatment.

2582. Screening for Abdominal Aortic Aneurysm: A Best-Evidence Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/teeHcmNgvNBSj4-E9SN5QK
      February 01, 2005 - To evaluate the potential harms associated with AAA screening and treatment (key questions 2 and 4), … Risk for AAA is significantly lower for black persons (OR, 0.53 [CI, 0.40 to 0.69]) and patients with diabetes … In MASS, for example, those attending screening may have benefited from improved treatment of hypertension … Treatment is associated with significant risks for operative death and complications. … Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men.

2583. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
      December 29, 2020 - therapy evaluated a single treatment session, potentially limiting the applicability of findings … Most alternative therapies are not covered by insurance. … • Heat therapy and massage: - A carefully designed active treatment plan has a greater impact … The report does not address multimodal therapies and in many cases treatments were not administered … The report does not address multimodal therapies and in many cases treatments were not administered

2584. RESEARCH FINDINGS #48: Influenza Vaccination Prevalence Among Adults with Increased Risk of Severe COVID-19
      meps.ahrq.gov/data_files/publications/rf48/rf48.shtml
      May 01, 2021 - For example, COVID-19 risk factors like obesity, diabetes, and heart disease occur disproportionately … Prior research has found higher influenza vaccination prevalence among adults with diabetes, heart disease … 30 kg/m2 or greater); age greater than or equal to 65; or any of the following treated conditions: diabetes … conditions associated with medical care, and no MEPS participants were reported to have received medical treatment … 9.4 (1.9) 47.0 (3.1) Risk factors       Diabetes

2585. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
      December 15, 2010 - is of perhaps greatest concern in the elderly.3,4 The use of CAM, which refers to preventive and therapeutic … , similarity of treatments. … participants at risk for cardiovascular disease, with known cardiovascular disease; participants with diabetes … Use of complementary therapies in patients with cardiovascular disease. … Herbal therapies and cardiac side effects. Prog Cardiovasc Nurs 2008;23:187-90. 17.

2586. Acknowledgments | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptmgmt/acknowledgements.html
      July 01, 2018 - Angeles Veterans Affairs Healthcare System Kathleen Clark Collaborative Director Washington State Diabetes

2587. Methodology | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptmgmt/methodology.html
      July 01, 2018 - " "telemedicine," and "chronic disease," "chronic illness," "high risk obstetrics or pregnancy," "diabetes

2588. 85-Vhmwwoglhd8Mvajt6Gq (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/85-VHmWWogLhD8mvajT6gq
      April 01, 2015 - ), and another study enrolled enough patients to detect an increase in the incidence of gestational diabetes … There was no relationship between supplementation and maternal hypertension (27, 30) or gestational diabetes … Iron supplement in pregnancy and development of gestational diabetes—a randomised placebo-controlled … Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011:CD003094. … Treatments for iron deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2001:CD003094.

2589. Implement Teamwork and Communication: | Agency for Healthcare Research and Quality
      www.ahrq.gov/hai/cusp/modules/implement/teamwork-notes.html
      December 01, 2012 - Communication Breakdowns Cause Treatment Delays Slide 7. … Communication Breakdowns Cause Treatment Delays 3 Say: Communication breakdowns are identified … as the primary root cause of treatment delays in the health care environment. … Other root causes for delays in treatment are: Patient assessment (77%), Continuum of care (52% … And, as this slide shows, there are many other causes of treatment delays.

2590. Appendix A Tables from Matar (2010) | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/stpra/stpraapamattabs.html
      April 01, 2018 - Preoperative Early    Host optimization       Improve control of glucose and ulcers in diabetes

2591. Archived: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2005
      July 05, 2005 - Serious or fatal maternal events are rare using currently recommended combination therapies. … Serious or fatal maternal events are rare using currently recommended combination therapies. … However, there are no completed trials showing clinical benefit from treatment versus no treatment in … limited and effective alternatives can often be found. 36 Metabolic disturbances (hyperlipidemia and diabetes … Meta-analysis of prophylactic treatments against Pneumocystic carinii pneumonia and toxoplasma encephalitis

2592. Challenges and Barriers to Clinical Decision Support (CDS) Design and Implementation Experienced in the Agency for Healthcare Research and Quality CDS Demonstrations (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/CDS_challenges_and_barriers.pdf
      July 30, 2007 - disease management and prevention screening that are common in adult ambulatory care settings, with diabetes … The guidelines selected for the project are: • American Diabetes Association’s Diabetes Management … • American College of Cardiology's guidelines on Antiplatelet Therapy Prescribed for Patients with … infrastructure also supports clinical reminders for the conditions targeted for this project (i.e., diabetes … Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and

2593. Statistical Brief #146
      hcup-us.ahrq.gov/reports/statbriefs/sb146.jsp
      January 01, 2013 - $10,100 $12,500 2.0% Biliary tract disease $3.5 $5.0 $7,700 $10,600 2.7% Diabetes … ; growth in cost per stay, 2.8%, growth in stays per population, 2.1%, growth in population, 1.0%, Diabetes … DRGs group patients according to diagnosis, type of treatment (procedures), age, and other relevant criteria … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or chemical

2594. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … intention is to enable tracking of medication adherence in patients with conditions such as tuberculosis, diabetes … Adherence to long-term therapies.

2595. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
      October 01, 2013 - Registries use an observational study design that does not specify treatments or require therapies … as HIV treatment, may not be pooled. … Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma … utilization patterns and cost of drug therapy. … Center for Education and Research on Therapeutics.

2596. Integrating Patient-Generated Health Data into Electronic Health Records in Ambulatory Care Settings: A Practical Guide (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/pghd-practical-guide.pdf
      December 01, 2021 - following categories and domains of PGHD: • Data gathered through queries or prompts— ◦ Health and Treatment … Histories Health and treatment histories may influence screening and diagnosis of disease, care planning … This goes for treatment of everything from depression to hypertension. … This is not new territory for clinicians, who have relied on PGHD to inform treatment decisions for … Journal of Diabetes Science and Technology. 2014;8(1):74-82.

2597. Assessing Applicability (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
      January 01, 2009 - A trial of etanercept for juvenile diabetes excluded patients with side effects during an active run-in … treatment effect size. … treatment effect size. … therapy. … Watchful waiting would be reasonable if the baseline treatment in both groups was standard medical therapy

2598. Nis 2013 Maskedstats Core (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core.PDF
      January 01, 2013 - PROC W/O CC/MCC 286 0.00% 637: DIABETES W MCC 11,453 0.16% 638: DIABETES W CC 35,781 0.50% 639: DIABETES … W MCC 5,273 0.07% 920: COMPLICATIONS OF TREATMENT W CC 7,896 0.11% 921: COMPLICATIONS OF TREATMENT … lower GI therapeutic procedures 17,278 0.24% 96: Other OR lower GI therapeutic procedures 24,511 0.34% … 8,887 0.12% 146: Treatment; fracture or dislocation of hip and femur 50,671 0.71% 147: Treatment; … radiology for cancer treatment 6,271 0.09% 212: Diagnostic physical therapy 1,800 0.03% 213: Physical

2599. AHRQ National Web Conference on the Role of Health IT to Improve Care Transitions - Slides (pdf file)
      digital.ahrq.gov/sites/default/files/docs/care-transitions-slides-092619.pdf
      September 26, 2019 - videos for each a ttending, play video for patient’s current attending by linking to the treatment … 9 (75) Medicaid insurance 12 (100) Race/ethnicity Black/Af-Am 8 (67) Hispanic/Latino 2 (17) Diabetes … ) Race/ethnicity Black/Af-Am 16 (28) Hispanic/Latino 33 (58) Limited health literacy 18 (32) Diabetes … "Patient race/ethnicity and shared medical record use among diabetes patients."

2600. Overview of Hospitalizations among Patients with COPD, 2008 (pdf file)
      hcup-us.ahrq.gov/reports/statbriefs/sb106.pdf
      February 14, 2011 - coexisting conditions that are also associated with tobacco use including cardiovascular disease and diabetes … Diabetes without complication and congestive heart failure (CHF) each occurred in about one-quarter of … 28.0%) 4 Disorders of lipid metabolism 228,400 (27.8%) 4 141,100 (27.5%) 4 87,300 (28.3%) 3 Diabetes … The principal procedure is the procedure that was performed for definitive treatment rather than performed